394 related articles for article (PubMed ID: 19109844)
1. Sildenafil therapy is associated with improved hemodynamics in liver transplantation candidates with pulmonary arterial hypertension.
Gough MS; White RJ
Liver Transpl; 2009 Jan; 15(1):30-6. PubMed ID: 19109844
[TBL] [Abstract][Full Text] [Related]
2. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
[TBL] [Abstract][Full Text] [Related]
3. Does Sildenafil produce a sustained benefit in patients with pulmonary hypertension associated with parenchymal lung and cardiac disease?
Madden BP; Sheth A; Wilde M; Ong YE
Vascul Pharmacol; 2007; 47(2-3):184-8. PubMed ID: 17627899
[TBL] [Abstract][Full Text] [Related]
4. The efficacy and safety of sildenafil in Chinese patients with pulmonary arterial hypertension.
Xu XQ; Jing ZC; Zhang JH; Wu Y; Wang Y; Jiang X; Wang ZX; Sun YG; Pu JL; Yang YJ
Hypertens Res; 2009 Oct; 32(10):911-5. PubMed ID: 19644505
[TBL] [Abstract][Full Text] [Related]
5. Sildenafil therapy in secondary pulmonary hypertension: Is there benefit in prolonged use?
Chapman TH; Wilde M; Sheth A; Madden BP
Vascul Pharmacol; 2009; 51(2-3):90-5. PubMed ID: 19386283
[TBL] [Abstract][Full Text] [Related]
6. Sildenafil for portopulmonary hypertension in a patient undergoing liver transplantation.
Makisalo H; Koivusalo A; Vakkuri A; Hockerstedt K
Liver Transpl; 2004 Jul; 10(7):945-50. PubMed ID: 15237383
[TBL] [Abstract][Full Text] [Related]
7. Use of sildenafil in heart transplant recipients with pulmonary hypertension may prevent right heart failure.
Maruszewski M; Zakliczyński M; Przybylski R; Kucewicz-Czech E; Zembala M
Transplant Proc; 2007 Nov; 39(9):2850-2. PubMed ID: 18021999
[TBL] [Abstract][Full Text] [Related]
8. Sildenafil and beraprost combination therapy in patients with pulmonary hypertension undergoing valvular heart surgery.
Kim SY; Shim JK; Shim YH; Hong SW; Choi KH; Kwak YL
J Heart Valve Dis; 2010 May; 19(3):333-40. PubMed ID: 20583396
[TBL] [Abstract][Full Text] [Related]
9. Sildenafil therapy for pulmonary arterial hypertension associated with atrial septal defects.
Lim ZS; Salmon AP; Vettukattil JJ; Veldtman GR
Int J Cardiol; 2007 May; 118(2):178-82. PubMed ID: 17027100
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and safety of treatment with sildenafil for secondary pulmonary hypertension in heart transplant candidates.
Zakliczynski M; Maruszewski M; Pyka L; Trybunia D; Nadziakiewicz P; Przybylski R; Zembala M
Transplant Proc; 2007 Nov; 39(9):2856-8. PubMed ID: 18022001
[TBL] [Abstract][Full Text] [Related]
11. Oral sildenafil reduces pulmonary hypertension after cardiac surgery.
Trachte AL; Lobato EB; Urdaneta F; Hess PJ; Klodell CT; Martin TD; Staples ED; Beaver TM
Ann Thorac Surg; 2005 Jan; 79(1):194-7; discussion 194-7. PubMed ID: 15620942
[TBL] [Abstract][Full Text] [Related]
12. Effects of chronic sildenafil use on pulmonary hemodynamics and clinical outcomes in heart transplantation.
Pons J; Leblanc MH; Bernier M; Cantin B; Bourgault C; Bergeron S; Proulx G; Morin J; Nalli C; O'Connor K; Chateauvert N; Sénéchal M
J Heart Lung Transplant; 2012 Dec; 31(12):1281-7. PubMed ID: 23127754
[TBL] [Abstract][Full Text] [Related]
13. Novel use of sildenafil in the treatment of portopulmonary hypertension.
Chua R; Keogh A; Miyashita M
J Heart Lung Transplant; 2005 Apr; 24(4):498-500. PubMed ID: 15797756
[TBL] [Abstract][Full Text] [Related]
14. Low-dose oral sildenafil for patients with pulmonary hypertension: a cost-effective solution in countries with limited resources.
Vida VL; Gaitan G; Quezada E; Barnoya J; Castañeda AR
Cardiol Young; 2007 Feb; 17(1):72-7. PubMed ID: 17184573
[TBL] [Abstract][Full Text] [Related]
15. Sarcoidosis-associated pulmonary hypertension: acute vasoresponsiveness to inhaled nitric oxide and the relation to long-term effect of sildenafil.
Milman N; Svendsen CB; Iversen M; Videbaek R; Carlsen J
Clin Respir J; 2009 Oct; 3(4):207-13. PubMed ID: 20298406
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary hypertension in end-stage pulmonary sarcoidosis: therapeutic effect of sildenafil?
Milman N; Burton CM; Iversen M; Videbaek R; Jensen CV; Carlsen J
J Heart Lung Transplant; 2008 Mar; 27(3):329-34. PubMed ID: 18342757
[TBL] [Abstract][Full Text] [Related]
17. Sildenafil for primary and secondary pulmonary hypertension.
Watanabe H; Ohashi K; Takeuchi K; Yamashita K; Yokoyama T; Tran QK; Satoh H; Terada H; Ohashi H; Hayashi H
Clin Pharmacol Ther; 2002 May; 71(5):398-402. PubMed ID: 12011826
[TBL] [Abstract][Full Text] [Related]
18. Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension.
Preston IR; Klinger JR; Houtches J; Nelson D; Farber HW; Hill NS
Respir Med; 2005 Dec; 99(12):1501-10. PubMed ID: 15890512
[TBL] [Abstract][Full Text] [Related]
19. Immediate and long-term hemodynamic and clinical effects of sildenafil in patients with pulmonary arterial hypertension receiving vasodilator therapy.
Bhatia S; Frantz RP; Severson CJ; Durst LA; McGoon MD
Mayo Clin Proc; 2003 Oct; 78(10):1207-13. PubMed ID: 14531479
[TBL] [Abstract][Full Text] [Related]
20. Chronic oral sildenafil therapy in severe pulmonary artery hypertension.
Kothari SS; Duggal B
Indian Heart J; 2002; 54(4):404-9. PubMed ID: 12462669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]